Shanghai Children's Medical Center

Running trials

• Not yet recruiting

  Hearing Intervention Effects on Brain and Language Development in Children With Bilateral Mild Hearing Loss

  NCT07774728· Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University· Source

• Recruiting

  The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature

  NCT07614152· Phase 3· Xiamen Amoytop Biotech Co., Ltd.· Source

• Not yet recruiting

  Multimodal Assisted Diagnosis for Pediatric Respiratory Diseases Using Questionnaires, Cough Sounds, and Breath Sounds

  NCT07613242· Shanghai Children's Medical Center· Source

• Recruiting

  Multimodal Tongue-Pulse Information Fusion for Syndrome Diagnosis and Cohort Study in Children With Asthma

  NCT07383883· Shanghai Children's Medical Center· Source

• Recruiting

  Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus

  NCT07425730· Shanghai Jiao Tong University School of Medicine· Source

• Recruiting

  Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease

  NCT07363538· Central China Fuwai Hospital of Zhengzhou University· Source

• Recruiting

  A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

  NCT07058077· Phase 2/3· Merck Sharp & Dohme LLC· Source

• Recruiting

  Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

  NCT07188012· Early phase 1· Shanghai Siponuoyin Biotechnology Co Ltd· Source

• Not yet recruiting

  Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

  NCT07035821· Phase 3· Shanghai Children's Medical Center· Source

• Recruiting

  Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents

  NCT07168980· Phase 2/3· Children's Cancer Group, China· Source

• Active, not recruiting

  A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD

  NCT06843408· Phase 1/2· Incyte Corporation· Source

• Recruiting

  Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

  NCT07326930· The Hong Kong Polytechnic University· Source

• Recruiting

  Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy

  NCT06900049· Early phase 1· Shanghai Jiao Tong University School of Medicine· Source

• Recruiting

  Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

  NCT06539624· The Children's Hospital of Zhejiang University School of Medicine· Source

• Recruiting

  Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment

  NCT06563245· Phase 2/3· Children's Cancer Group, China· Source

• Recruiting

  A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

  NCT06927466· Phase 1· Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.· Source

• Active, not recruiting

  A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease

  NCT06528080· Early phase 1· Shanghai Jiao Tong University School of Medicine· Source

• Active, not recruiting

  Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

  NCT06054113· Phase 2· Amgen· Source

• Recruiting

  Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

  NCT06607419· Phase 2/3· Shanghai Jiao Tong University School of Medicine· Source

• Enrolling by invitation

  National Multicenter Registry for Pediatric End-Stage Heart Failure in China

  NCT06927440· Shanghai Jiao Tong University School of Medicine· Source

• Recruiting

  A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

  NCT05319353· Phase 3· Takeda· Source

• Recruiting

  Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)

  NCT05681260· Phase 3· Children's Cancer Group, China· Source

• Recruiting

  A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

  NCT04478292· Phase 3· Shanghai Children's Medical Center· Source

• Active, not recruiting

  CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL

  NCT04881838· Phase 3· Children's Cancer Group, China· Source

• Recruiting

  Overweight and Obesity and Puberty Development Cohort Study

  NCT04113070· Shanghai Jiao Tong University School of Medicine· Source

• Recruiting

  Construction of a Multi-center Clinical Research Collaboration Network for Children with Congenital Heart Disease in China

  NCT06885307· Xinhua Hospital, Shanghai Jiao Tong University School of Medicine· Source

• Active, not recruiting

  CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma

  NCT04726501· Phase 4· Children's Cancer Group, China· Source

• Active, not recruiting

  LBL-2016 for Children or Adolescents in China

  NCT02845882· Phase 3· Children's Cancer Group, China· Source

• Recruiting

  Shanghai Epidemiology Study for Adolescents and Children With Cancer

  NCT02959086· Children's Cancer Group, China· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers8 recruiting
• Acute lymphoblastic leukaemia3 recruiting
• Asthma2 recruiting
• Congenital heart disease2 recruiting
• Duchenne muscular dystrophy2 recruiting
• Cytomegalovirus infection1 recruiting
• Fabry disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Hearing loss1 recruiting
• Heart failure1 recruiting
• Lupus (SLE)1 recruiting
• Obesity1 recruiting
• Turner syndrome1 recruiting

Closed trials

• Completed

  Study on AI Recognition System Of Heart Sound In Congenital Heart Disease Screening

  NCT04307030· Xinhua Hospital, Shanghai Jiao Tong University School of Medicine· Source

• Completed

  A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

  NCT02932410· Phase 3· Actelion· Source

• Completed

  Vinorelbine for Recurrent ALCL-2017

  NCT03443128· Phase 2· Children's Cancer Group, China· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Congenital heart disease42 works · 3 trials
• Acute lymphoblastic leukaemia18 works · 4 trials
• Neuroblastoma17 works · 0 trials
• Pulmonary arterial hypertension14 works · 1 trial